Real-world experience of niraparib as maintenance therapy in newly diagnosed advanced ovarian cancer: A singlecenter retrospective study

被引:0
|
作者
Wenxin, L. [1 ]
Wang, K. [1 ]
Zhang, L. [1 ]
Ma, Y. [1 ]
Wu, H. [1 ]
Chen, Y. [1 ]
Bao, L. [1 ]
Fu, X. [1 ]
机构
[1] TMUCIH Tianjin Med Univ Canc Inst & Hosp, Dept Gynecol Oncol, Tianjin, Peoples R China
关键词
D O I
10.1016/j.annonc.2023.10.436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
315P
引用
收藏
页码:S1594 / S1594
页数:1
相关论文
共 50 条
  • [21] Patient characteristics, treatment patterns and real-world effectiveness of niraparib in France: an ESME retrospective study in recurrent ovarian cancer patients treated with niraparib maintenance
    Gladieff, Laurence
    Macouillard, Pauline
    Toussaint, Philippe
    El-Mouaddin, Nadia
    Jacquemin, Virginie
    Fages, Anne
    Nachbaur, Gaelle
    Gourgou, Sophie
    Pomel, Christophe
    Colombo, Pierre-Emmanuel
    Bosquet, Lise
    Rodrigues, Manuel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A307 - A308
  • [22] Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer A Phase 3 Randomized Clinical Trial
    Li, Ning
    Zhu, Jianqing
    Yin, Rutie
    Wang, Jing
    Pan, Lingya
    Kong, Beihua
    Zheng, Hong
    Liu, Jihong
    Wu, Xiaohua
    Wang, Li
    Huang, Yi
    Wang, Ke
    Zou, Dongling
    Zhao, Hongqin
    Wang, Chunyan
    Lu, Weiguo
    Lin, An
    Lou, Ge
    Li, Guiling
    Qu, Pengpeng
    Yang, Hongying
    Zhang, Yu
    Cai, Hongbing
    Pan, Yueyin
    Hao, Min
    Liu, Ziling
    Cui, Heng
    Yang, Yingjie
    Yao, Shuzhong
    Zhen, Xiaoa
    Hang, Wenzhao
    Hou, Jianmei
    Wang, Juan
    Wu, Lingying
    JAMA ONCOLOGY, 2023, 9 (09) : 1230 - 1237
  • [24] Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer
    Kim, Ji Hyun
    Kim, Se Ik
    Park, Eun Young
    Kim, Eun Taeg
    Kim, Hyesu
    Kim, Sangeon
    Park, Sang-Yoon
    Lim, Myong Cheol
    GYNECOLOGIC ONCOLOGY, 2024, 181 : 33 - 39
  • [25] First evidence of olaparib maintenance therapy in patients with newly diagnosed BRCA wild-type ovarian cancer: A real-world multicenter study
    Li, J.
    Youguo, C.
    Mian, H.
    Chen, X.
    Wen, H.
    Kang, Y.
    Liu, K. J.
    Lou, G.
    Wang, X.
    Wen, Q. L.
    Wang, L.
    Lin, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S1594 - S1595
  • [26] Real world clinical outcomes of niraparib first line maintenance therapy in patients with BRCA wildtype advanced ovarian cancer
    Piedimonte, Sabrina
    Clarfield, Lauren
    Manley, Mollie
    Kupets, Rachel
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A325 - A325
  • [27] Patterns in maintenance therapy use in advanced ovarian cancer patients: Real-world data analysis
    Taylor, Sarah
    Gart, Michael
    Choksi, Rushir
    Thomas, Roby
    Katzen, Harvey
    Donegan, Janet
    Vasudevan, Anupama
    Alwon, Erin
    Varughese, Prateesh
    Blanc, Simon
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S333 - S333
  • [28] Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?
    Liu, Jinan
    Thaker, Premal H.
    Sah, Janvi
    Maiese, Eric M.
    Bee, Oscar
    Hurteau, Jean
    Chan, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Real-world patterns and predictors of first-line maintenance use among patients with newly diagnosed advanced ovarian cancer: Is there an opportunity for change?
    Liu, Jinan
    Thaker, Premal H.
    Sah, Janvi
    Maiese, Eric M.
    Bee, Oscar
    Hurteau, Jean
    Chan, John
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [30] Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)
    Liontos, Michalis
    Timotheadou, Eleni
    Papadopoulos, Emmanuel I.
    Zafeiriou, Zafeiris
    Lampropoulou, Dimitra Ioanna
    Aravantinos, Gerasimos
    Mavroudis, Dimitrios
    Christodoulou, Christos
    Nikolaidi, Adamantia
    Somarakis, Alvertos
    Papadimitriou, Christos
    Papandreou, Christos
    Bamias, Aristotelis
    CURRENT ONCOLOGY, 2021, 28 (06) : 5266 - 5277